Temporal trends in the primary prevention of implantable cardioverter-defibrillator selection and long-term outcomes in patients with non-ischaemic dilated cardiomyopathy and ischaemic cardiomyopathy
Europace · 30.03.2026 · 28 (4)
DOI: 10.1093/europace/euag062 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Europace, online erschienen am 07.04.2026. Verfasst von Thuy Mi Nguyen und 9 weiteren Autor:innen. Beteiligte Einrichtung: ProCardio Center for Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet Sognsvannsveien 20, PO Box 4950 Nydalen, Oslo NO-…. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Cardiomyopathy, Dilated, Primary Prevention, Myocardial Ischemia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norwegian Health Association, South-Eastern Norway regional health, Norwegian Research Council.
Abstract (Originalsprache)
Aims
The effect of primary prevention ICD (ppICD) in non-ischaemic dilated cardiomyopathy (DCM) remains debated. We investigated long-term outcomes and the incidence of ppICD therapy in patients with DCM and ischaemic cardiomyopathy (ICM), comparing implants before and after 2017. Methods and results We prospectively included ppICD patients from the multicentre IMPROVE study (2014–2022) with DCM and ICM. All underwent ECG and echocardiography at baseline. The primary outcome was appropriate ICD therapy; the secondary outcome was all-cause mortality. Outcomes were compared pre- and post-2017 in DCM and ICM patients. Among 393 ppICD patients (median age 66, 15% female), 115 had DCM (66 post-2017, 49 pre-2017) and 278 had ICM (165 post-2017, 113 pre-2017). DCM post-2017 patients were younger (54 vs. 64 years, P < 0.01) and had a higher left ventricular ejection fraction (LVEF) (33% vs. 24%, P < 0.001) compared to DCM pre-2017 patients. Nevertheless, ICD therapy [4.0 vs. 3.1/100 person-years (PY), P = 0.57] and all-cause mortality rates (2.0 vs. 4.7/100 PY, P = 0.09) were similar. ICM post-2017 patients had a slightly higher LVEF (31% vs. 29%, P = 0.04), fewer ICD therapies (3.1 vs. 6.2/100 PY, P = 0.01), and similar mortality rates (6.3 vs. 8.3/100 PY, P = 0.18) compared to pre-2017.
Conclusion
Patient selection for ppICD in DCM changed post-2017, with a shift towards younger patients and better LVEF compared to those implanted pre-2017; however, appropriate ICD therapy and all-cause mortality rates remained unchanged. In ICM, lower ICD therapy rates post-2017 may reflect improvement in revascularization and heart failure treatments. Trial Registration ClinicalTrials.gov Identifier: NCT02286908
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- ProCardio Center for Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet Sognsvannsveien 20, PO Box 4950 Nydalen, Oslo NO-0424, Norway.
- Institute of Clinical Medicine, University of Oslo, PO Box 1171 Blindern, Oslo 0318, Norway.
- Department of Cardiology, Hospital of Southern Norway, Kristiansand 4604, Norway.
- Department of Medicine, Drammen Hospital, Vestre Viken Hospital, Vestre Viken HF, PO Box 800, Drammen 3004, Norway.
- Department of Cardiology, University Hospital of North Norway HF, Postboks 100, Tromsø 9038, Norway.
- Department of Cardiology, Helse Stavanger HF, Postboks 8100, Stavanger 4068, Norway.
ORCID-Profile: Thuy Mi Nguyen, Daniela Melichova, Ivar Mjåland Salte, Erik Gjertsen, Øyunn Kleiven, Thor Edvardsen, Kristina Haugaa
Förderung
- Norwegian Health Association
- South-Eastern Norway regional health
- Norwegian Research Council
- ProCardio
Zitieren
APA
Nguyen, T. M., Melichova, D., Aabel, E. W., Salte, I. M., Gjertsen, E., Heggelund, G., Kleiven, Ø., Brunvand, H., Edvardsen, T., & Haugaa, K. (2026). Temporal trends in the primary prevention of implantable cardioverter-defibrillator selection and long-term outcomes in patients with non-ischaemic dilated cardiomyopathy and ischaemic cardiomyopathy. Europace, 28(4). https://doi.org/10.1093/europace/euag062
Vancouver
Nguyen TM, Melichova D, Aabel EW, Salte IM, Gjertsen E, Heggelund G, et al. Temporal trends in the primary prevention of implantable cardioverter-defibrillator selection and long-term outcomes in patients with non-ischaemic dilated cardiomyopathy and ischaemic cardiomyopathy. Europace. 2026;28(4). doi:10.1093/europace/euag062
BibTeX
@article{Nguyen2026,
author = {Nguyen, Thuy Mi and Melichova, Daniela and Aabel, Eivind Westrum and Salte, Ivar Mjåland and Gjertsen, Erik and Heggelund, Geir and Kleiven, Øyunn and Brunvand, Harald and Edvardsen, Thor and Haugaa, Kristina},
title = {Temporal trends in the primary prevention of implantable cardioverter-defibrillator selection and long-term outcomes in patients with non-ischaemic dilated cardiomyopathy and ischaemic cardiomyopathy},
journal = {Europace},
year = {2026},
volume = {28},
number = {4},
doi = {10.1093/europace/euag062}
}
EUVIMED